Medicines Co. Stock
Your prediction
Pros and Cons of Medicines Co. in the next few years
Pros
?
S********** s********
?
W********* I********* f** t** n*** y****
?
B****
Cons
?
M***** P*******
?
C******** o* t** e**********
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Medicines Co. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Medicines Co. | - | - | - | - | - | - | - |
| Repligen Corp. | -4.860% | -7.030% | -19.749% | -20.179% | -20.660% | -39.068% | -40.400% |
| Opko Health Inc. | 1.420% | -1.724% | -5.538% | -33.699% | -7.999% | -7.336% | -79.102% |
| Amicus Therapeutics Inc. | 0.000% | 0.840% | -1.639% | 31.868% | 0.000% | 4.803% | 14.286% |
Comments
News
Biotech Stock Up 266%: This New $55 Million Bet Signals Conviction in Praxis Amid Pipeline Progress
On February 13, 2026, Affinity Asset Advisors disclosed a new position in Praxis Precision Medicines (NASDAQ:PRAX), acquiring 185,000 shares in an estimated $54.53 million trade.
According to a SEC
Why Revolution Medicines Stock Plummeted by Almost 17% Today
Monday was generally a good day for the stock market; nevertheless, some titles landed in negative territory. One that plunged well into the red was clinical-stage biotech Revolution Medicines
Why Revolution Medicines Stock Surged by 11% Today
More often than not, takeover speculation can give a lively boost -- at least in the short term -- to a company's stock. That was the dynamic behind the nearly 11% price gain of Revolution Medicines